BC Innovations | Jun 28, 2019
Product Development

How Array stayed alive long enough to grow up

Array’s 21-year journey as an independent platform company, culminating in an $11.4 billion buyout, required shifting focus from research to development and back again. The acquisition sends a message that developing focused expertise and sticking...
BC Extra | Jun 28, 2019
Company News

Management tracks: Gottlieb joins Pfizer board; plus Adaptimmune, Xencor, Arcus and more

Pfizer Inc. (NYSE:PFE) appointed former FDA Commissioner Scott Gottlieb to its board. Gottlieb is joining the board's regulatory and compliance and science and technology committees. Since leaving the FDA in early April, Gottlieb returned to...
BioCentury | Jul 13, 2018
Strategy

Roche’s partnering priority

As James Sabry gets set to lead partnering for all of Roche pharma, his first order of business might be to build out the company’s late-stage pipeline ahead of an impending patent cliff that puts...
BioCentury | Aug 18, 2017
Finance

IPF call options

Surprise readouts from two programs in idiopathic pulmonary fibrosis have generated over $1.4 billion in market value, and there could still be plenty of upside ahead. After market close on Aug. 7, FibroGen Inc. (NASDAQ:FGEN)...
BC Extra | May 15, 2017
Financial News

Genoa's series A brings in $62M

Pulmonary play Genoa Pharmaceuticals Inc. (Seattle, Wash.) said it raised $62 million in a series A financing led by F-Prime Capital Partners and Edmond de Rothschild Investment Partners . Also participating were Novo A/S (Hellerup, Denmark),...
BC Extra | Feb 26, 2016
Company News

Management tracks

Gene therapy company bluebird bio Inc. (NASDAQ:BLUE) said CFO Jim DeTore resigned, effective March 18. bluebird COO Jeffrey Walsh will become CFO and chief strategy officer, effective March 1. Walsh will step down as COO...
BC Extra | Sep 30, 2015
Company News

Management tracks

Cancer diagnostics company Agendia N.V. (Amsterdam, the Netherlands) named Mark Straley CEO. Straley was president, anatomical pathology at Thermo Fisher Scientific Inc. (NYSE:TMO). Renal company Genkyotex S.A. (Plan-les-Ouates, Switzerland) said CEO Ursula Ney will resign...
BC Extra | Jul 22, 2015
Company News

Management tracks

The MedImmune LLC unit of AstraZeneca plc (LSE:AZN; NYSE:AZN) hired David Berman as SVP and head of its oncology innovative medicines unit. He will succeed Edward Bradley, who will serve in an advisory role until...
BC Extra | Jul 7, 2015
Company News

Management tracks

CNS play Zogenix Inc. (NASDAQ:ZGNX) hired Gail Farfel as EVP and chief development officer and Thierry Darcis as EVP and general manager of Europe. Farfel was chief clinical and regulatory officer at Marinus Pharmaceuticals Inc....
BC Extra | Jun 19, 2015
Company News

Management tracks

Gene therapy company AveXis Inc. (Dallas, Texas) hired Sean Nolan as CEO. He replaces John Carbona, who resigned in April. Nolan was CBO at InterMune Inc. , which Roche (SIX:ROG; OTCQX:RHHBY) acquired. Ophthalmic company Envisia Therapeutics...
Items per page:
1 - 10 of 830
BC Innovations | Jun 28, 2019
Product Development

How Array stayed alive long enough to grow up

Array’s 21-year journey as an independent platform company, culminating in an $11.4 billion buyout, required shifting focus from research to development and back again. The acquisition sends a message that developing focused expertise and sticking...
BC Extra | Jun 28, 2019
Company News

Management tracks: Gottlieb joins Pfizer board; plus Adaptimmune, Xencor, Arcus and more

Pfizer Inc. (NYSE:PFE) appointed former FDA Commissioner Scott Gottlieb to its board. Gottlieb is joining the board's regulatory and compliance and science and technology committees. Since leaving the FDA in early April, Gottlieb returned to...
BioCentury | Jul 13, 2018
Strategy

Roche’s partnering priority

As James Sabry gets set to lead partnering for all of Roche pharma, his first order of business might be to build out the company’s late-stage pipeline ahead of an impending patent cliff that puts...
BioCentury | Aug 18, 2017
Finance

IPF call options

Surprise readouts from two programs in idiopathic pulmonary fibrosis have generated over $1.4 billion in market value, and there could still be plenty of upside ahead. After market close on Aug. 7, FibroGen Inc. (NASDAQ:FGEN)...
BC Extra | May 15, 2017
Financial News

Genoa's series A brings in $62M

Pulmonary play Genoa Pharmaceuticals Inc. (Seattle, Wash.) said it raised $62 million in a series A financing led by F-Prime Capital Partners and Edmond de Rothschild Investment Partners . Also participating were Novo A/S (Hellerup, Denmark),...
BC Extra | Feb 26, 2016
Company News

Management tracks

Gene therapy company bluebird bio Inc. (NASDAQ:BLUE) said CFO Jim DeTore resigned, effective March 18. bluebird COO Jeffrey Walsh will become CFO and chief strategy officer, effective March 1. Walsh will step down as COO...
BC Extra | Sep 30, 2015
Company News

Management tracks

Cancer diagnostics company Agendia N.V. (Amsterdam, the Netherlands) named Mark Straley CEO. Straley was president, anatomical pathology at Thermo Fisher Scientific Inc. (NYSE:TMO). Renal company Genkyotex S.A. (Plan-les-Ouates, Switzerland) said CEO Ursula Ney will resign...
BC Extra | Jul 22, 2015
Company News

Management tracks

The MedImmune LLC unit of AstraZeneca plc (LSE:AZN; NYSE:AZN) hired David Berman as SVP and head of its oncology innovative medicines unit. He will succeed Edward Bradley, who will serve in an advisory role until...
BC Extra | Jul 7, 2015
Company News

Management tracks

CNS play Zogenix Inc. (NASDAQ:ZGNX) hired Gail Farfel as EVP and chief development officer and Thierry Darcis as EVP and general manager of Europe. Farfel was chief clinical and regulatory officer at Marinus Pharmaceuticals Inc....
BC Extra | Jun 19, 2015
Company News

Management tracks

Gene therapy company AveXis Inc. (Dallas, Texas) hired Sean Nolan as CEO. He replaces John Carbona, who resigned in April. Nolan was CBO at InterMune Inc. , which Roche (SIX:ROG; OTCQX:RHHBY) acquired. Ophthalmic company Envisia Therapeutics...
Items per page:
1 - 10 of 830